CD123-targeted CAR-T
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD123-targeted CAR-T, covering 2019-06-25 to 2019-06-25. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Research of CD123-Targeted CAR-T in Myeloid Malignancies [Phase 1, Phase 2]